Blog
RSS FeedPosted by Michael Wonder on 24 Nov 2020
GPs frustrated by PHARMAC’s lack of progress on better meds for type 2 diabetics
24 November 2020 - PHARMAC has put the brakes on two new medications that would greatly improve treatment options for ...
Posted by Michael Wonder on 23 Nov 2020
Woman trying to raise $110,000 a month for life-extending breast cancer treatment
23 November 2020 - “Pay up or die” is the choice for a woman in her 30s trying to raise ...
Posted by Michael Wonder on 23 Nov 2020
Funding changes to dornase alfa for cystic fibrosis
23 November 2020 - From 1 December 2020 dornase alfa will be listed in the Community and the Hospital Medicines List ...
Posted by Michael Wonder on 17 Nov 2020
PHARMAC and Diabetes Foundation Aotearoa locked in stand-off over drug funding decision
17 November 2020 - The Diabetes Foundation Aotearoa is calling on drug funding agency PHARMAC to release the submissions it ...
Posted by Michael Wonder on 15 Nov 2020
New drug gives 'normal life' to haemophiliac who thought he would never study, surf or be on stage
15 November 2020 - Performing on stage, going to university and surfing are things Andrew Scott never thought he would ...
Posted by Michael Wonder on 12 Nov 2020
PHARMAC won’t release the data that changed its mind on diabetes
13 November 2020 - Diabetes Foundation Aotearoa will request the Ombudsman investigate the refusal by PHARMAC to release public submissions ...
Posted by Michael Wonder on 12 Nov 2020
Proposal to widen access to valganciclovir for transplant patients
12 November 2020 - PHARMAC is seeking feedback on a proposal to widen access to valganciclovir. ...
Posted by Michael Wonder on 11 Nov 2020
Decision to widen access to treatments for juvenile idiopathic arthritis
11 November 2020 - PHARMAC is pleased to announce a decision to widen access to adalimumab and etanercept for the ...
Posted by Michael Wonder on 10 Nov 2020
PHARMAC to fund new haemophilia medicine
11 November 2020 - From 1 December 2020 a new medicine will be funded by PHARMAC which will help some people ...
Posted by Michael Wonder on 04 Nov 2020
Update on proposal to fund two new medicines for type 2 diabetes mellitus
5 November 2020 - PHARMAC would like to thank everyone who provided feedback on a proposal to fund two new medicines, ...
Posted by Michael Wonder on 04 Nov 2020
Pregabalin: supply issue
4 November 2020 - Due to shipping delays, there will be a brief out of stock of Pfizer Pregabalin. ...
Posted by Michael Wonder on 03 Nov 2020
PHARMAC funding resources to focus on medicines access equity
3 November 2020 - PHARMAC is pleased to announce the launch of He Ako Hiringa, a clinical education provider with ...
Posted by Michael Wonder on 01 Nov 2020
New Zealand Pharmaceutical Schedule - 1 November 2020
1 November 2020 - The November 2020 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 29 Oct 2020
PTAC recommends the reimbursement of osimertinib mesylate for the first-line treatment of patients with locally advanced or metastatic epidermal growth factor receptor mutated non-small cell lung cancer
29 October 2020 - PTAC has acknowledged the high unmet clinical need and the high quality, randomised control trial evidence ...
Posted by Michael Wonder on 29 Oct 2020
PHARMAC needs a short, sharp dose of reality
29 October 2020 - Wiki Mulholland was diagnosed with breast cancer in 2018 and is fighting for PHARMAC to fund drugs ...